Related Experiment Video
Updated: Apr 5, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Mas receptor deficiency exacerbates lipopolysaccharide-induced cerebral and systemic inflammation in mice
Onésia C Oliveira-Lima1, Mauro C X Pinto2, Johan Duchene3
1Departamento de Fisiologia e Biofísica, Instituto de Ciência Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Abstract:
Beyond the classical actions of the renin-angiotensin system on the regulation of cardiovascular homeostasis, several studies have shown its involvement in acute and chronic inflammation. The G protein-coupled receptor Mas is a functional binding site for the angiotensin-(1-7); however, its role in the immune system has not been fully elucidated. In this study, we evaluated the effect of genetic deletion of Mas receptor in lipopolysaccharide (LPS)-induced systemic and cerebral inflammation in mice. Inflammatory response was triggered in Mas deficient (Mas(-/-)) and C57BL/6 wild-type (WT) mice (8-12 weeks-old) by intraperitoneal injection of LPS (5 mg/kg). Mas(-/-) mice presented more intense hypothermia compared to WT mice 24 h after LPS injection. Systemically, the bone marrow of Mas(-/-) mice contained a lower number of neutrophils and monocytes 3 h and 24 h after LPS injection, respectively. The plasma levels of inflammatory mediators KC, MCP-1 and IL-10 were higher in Mas(-/-) mice 24 h after LPS injection in comparison to WT. In the brain, Mas(-/-) animals had a significant increase in the number of adherent leukocytes to the brain microvasculature compared to WT mice, as well as, increased number of monocytes and neutrophils recruited to the pia-mater. The elevated number of adherent leukocytes on brain microvasculature in Mas(-/-) mice was associated with increased expression of CD11b - the alpha-subunit of the Mac-1 integrin - in bone marrow neutrophils 3h after LPS injection, and with increased brain levels of chemoattractants KC, MIP-2 and MCP-1, 24 h later. In conclusion, we demonstrated that Mas receptor deficiency results in exacerbated inflammation in LPS-challenged mice, which suggest a potential role for the Mas receptor as a regulator of systemic and brain inflammatory response induced by LPS.
Insights
Mice lacking the Mas receptor showed worsened inflammation and immune cell changes after lipopolysaccharide (LPS) exposure, suggesting Mas receptor regulates inflammatory responses.
Area of Science:
- Immunology
- Neuroscience
- Cardiovascular Biology
Background:
- The renin-angiotensin system influences cardiovascular homeostasis and inflammation.
- The Mas receptor, a target for angiotensin-(1-7), has an incompletely understood role in immunity.
Purpose of the Study:
- To investigate the impact of Mas receptor genetic deletion on lipopolysaccharide (LPS)-induced systemic and brain inflammation in mice.
Main Methods:
- Mas receptor deficient (Mas(-/-)) and wild-type (WT) mice were challenged with LPS.
- Evaluated hypothermia, immune cell counts (neutrophils, monocytes), plasma inflammatory mediators, and brain leukocyte adhesion.
Main Results:
- Mas(-/-) mice exhibited exacerbated hypothermia, altered neutrophil and monocyte counts, and elevated inflammatory mediators (KC, MCP-1, IL-10) post-LPS.
- Increased leukocyte adhesion to brain microvasculature and enhanced neutrophil/monocyte recruitment to the pia-mater were observed in Mas(-/-) mice.
- Leukocyte adhesion correlated with increased CD11b expression and elevated brain chemoattractants (KC, MIP-2, MCP-1).
Conclusions:
- Mas receptor deficiency leads to heightened systemic and cerebral inflammation in response to LPS.
- The Mas receptor may play a crucial role in modulating LPS-induced inflammatory responses in both the body and the brain.
More Related Videos
07:31Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
Published on: August 23, 2022
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018